Free Trial
OTCMKTS:CBDS

Cannabis Sativa (CBDS) Stock Price, News & Analysis

Cannabis Sativa logo
$0.01
0.00 (0.00%)
(As of 10/31/2024 ET)

About Cannabis Sativa Stock (OTCMKTS:CBDS)

Key Stats

Today's Range
$0.0101
$0.0115
50-Day Range
$0.0040
$0.0139
52-Week Range
$0.00
$0.03
Volume
23,072 shs
Average Volume
202,152 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Cannabis Sativa Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
3rd Percentile Overall Score

CBDS MarketRank™: 

Cannabis Sativa scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cannabis Sativa is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cannabis Sativa is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cannabis Sativa has recently increased by 12,000.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cannabis Sativa does not currently pay a dividend.

  • Dividend Growth

    Cannabis Sativa does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cannabis Sativa has recently increased by 12,000.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cannabis Sativa has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cannabis Sativa this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cannabis Sativa insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.46% of the stock of Cannabis Sativa is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Cannabis Sativa's insider trading history.
Receive CBDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Sativa and its competitors with MarketBeat's FREE daily newsletter.

CBDS Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Dabney: My journey with cannabis
See More Headlines

CBDS Stock Analysis - Frequently Asked Questions

Cannabis Sativa's stock was trading at $0.0090 on January 1st, 2024. Since then, CBDS stock has increased by 20.0% and is now trading at $0.0108.
View the best growth stocks for 2024 here
.

Shares of CBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Sativa investors own include Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), 22nd Century Group (XXII) and Sangamo Therapeutics (SGMO).

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:CBDS
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (OTCMKTS:CBDS) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners